Success Story: With Our Guidance, A Chinese Postdoctoral Scholar Secure EB1A Approval
Client’s Testimonial:
“Thank you very much for your kind message and for all your support throughout the I-140 EB1A process. I truly appreciate your guidance and expertise.”
On May 19th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Scholar in the Field of Biology (Approval Notice).
General Field: Biology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: May 19th, 2025
Processing Time: 12 months, 5 days
Case Summary:
We are pleased to share the success story of a distinguished biologist whose I-140 EB1A (Extraordinary Ability) petition was approved just over a year after filing without any RFE. This case exemplifies how consistent contributions to high-impact research in molecular biology and bioinformatics can meet the rigorous standards of the EB1A category.
Our client holds a Ph.D. in pharmaceutical sciences with an emphasis in pharmacognosy and is actively engaged in research spanning bioinformatics analysis, clinical data processing, and cardiovascular molecular biology. Her proposed endeavor focuses on uncovering the role of key enzymes and microbes in disease progression and recovery - critical knowledge that could improve diagnostic tools and therapeutic development in cardiovascular and metabolic health.
The petition, filed under the EB1A category, featured:
● 16 peer-reviewed journal articles,
● 1,042 total citations according to Google Scholar,
● 21 completed peer reviews for respected scientific journals.
Our legal team highlighted her substantial influence in the field, especially her studies identifying enzyme functions and microbial signatures that correlate with disease outcomes. These findings have proven valuable not only for advancing fundamental science but also for guiding clinical applications in precision medicine and drug discovery.We also emphasized that her work has been backed by competitive research funding from the National Science Foundation of China (NSFC) and the Science and Technology Program of Guangzhou, clear indicators of both scientific merit and real-world relevance.
To further support the petition, four compelling letters of recommendation were submitted by experts in molecular biology and biomedical research. These letters independently affirmed her expertise and the far-reaching value of her findings.
“Coupled with skill and influence, [Client] is indeed, a leader in the field of biology and her work must be allowed to continue.”
Through a carefully crafted petition, NAILG demonstrated that this biologist is not only an established authority in her field but also exceptionally well-positioned to continue making important contributions to the United States. We congratulate her on this milestone and look forward to the continued impact of her work in biomedical innovation.